Cronos Group Inc. financial data

Symbol
CRON on Nasdaq
Industry
Medicinal Chemicals & Botanical Products
Location
4491 Concession Rd 12, Stayner, Ontario, Canada
State of incorporation
British Columbia, Canada
Fiscal year end
December 31
Former names
PharmaCan Capital Corp. (to 5/27/2016)
Latest financial report
10-K - Q4 2024 - Feb 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.42K % -15.3%
Quick Ratio 90 % -25.4%
Debt-to-equity 4.18 % +31.8%
Return On Equity 3.76 %
Return On Assets 3.61 %
Operating Margin -65.1 % +33.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 383M shares +0.14%
Common Stock, Shares, Outstanding 383M shares +0.32%
Entity Public Float 458M USD +17%
Common Stock, Value, Issued 670M USD +1.16%
Weighted Average Number of Shares Outstanding, Basic 382M shares +0.29%
Weighted Average Number of Shares Outstanding, Diluted 386M shares +1.21%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 118M USD +34.8%
Research and Development Expense 4.23M USD -27.6%
Selling and Marketing Expense 21.6M USD -4.84%
General and Administrative Expense 46.5M USD -5.99%
Operating Income (Loss) -76.5M USD +9.75%
Nonoperating Income (Expense) 113M USD +916%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 36.6M USD
Income Tax Expense (Benefit) -3.44M USD -6.38%
Net Income (Loss) Attributable to Parent 41.1M USD
Earnings Per Share, Basic 0.11 USD/shares
Earnings Per Share, Diluted 0.11 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 859M USD +28.3%
Cash, Cash Equivalents, and Short-term Investments 859M USD -0.32%
Accounts Receivable, after Allowance for Credit Loss, Current 15.5M USD +10.6%
Inventory, Net 33.1M USD +8.7%
Assets, Current 936M USD +0.3%
Other Long-term Investments 2.81M USD -92%
Deferred Income Tax Assets, Net 2.57M USD +1038%
Property, Plant and Equipment, Net 133M USD +124%
Operating Lease, Right-of-Use Asset 1.39M USD +2.51%
Intangible Assets, Net (Excluding Goodwill) 11.3M USD -46.6%
Goodwill 63.5M USD +5903%
Other Assets, Noncurrent 130K USD
Assets 1.17B USD +2.28%
Accounts Payable, Current 17M USD +39.9%
Employee-related Liabilities, Current 10.3M USD +15.1%
Accrued Liabilities, Current 31.7M USD +14.1%
Liabilities, Current 49.7M USD +20.1%
Deferred Income Tax Liabilities, Net 3.56M USD +1869%
Operating Lease, Liability, Noncurrent 993K USD -36.3%
Other Liabilities, Noncurrent 1.07M USD +6.98%
Liabilities 55.3M USD +25.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -63.5M USD -407%
Retained Earnings (Accumulated Deficit) 458M USD +9.84%
Stockholders' Equity Attributable to Parent 1.06B USD -3.23%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1.11B USD +1.36%
Liabilities and Equity 1.17B USD +2.28%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.2M USD +95.4%
Net Cash Provided by (Used in) Financing Activities -645K USD +13.2%
Net Cash Provided by (Used in) Investing Activities 190M USD
Common Stock, Shares, Issued 383M shares +0.32%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 186M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 859M USD +28.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 200M USD -7.38%
Deferred Tax Assets, Gross 203M USD -6.29%
Operating Lease, Liability 2.02M USD -21%
Payments to Acquire Property, Plant, and Equipment 1.72M USD +114%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -43.1M USD +17.8%
Lessee, Operating Lease, Liability, to be Paid 2.4M USD -19.6%
Property, Plant and Equipment, Gross 299M USD
Operating Lease, Liability, Current 1.03M USD +3.12%
Lessee, Operating Lease, Liability, to be Paid, Year Two 382K USD -62%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.15M USD +1.24%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 383K USD -11.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 229K USD -7.29%
Deferred Tax Assets, Operating Loss Carryforwards 96.3M USD -13.6%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 229K USD +141%
Additional Paid in Capital 51.5M USD +9.31%
Depreciation, Depletion and Amortization 1.73M USD -28%
Deferred Tax Assets, Net of Valuation Allowance 2.57M USD +1038%
Share-based Payment Arrangement, Expense 8.7M USD -0.64%